Announcement

Collapse
No announcement yet.

J Med Cases . Toxic Epidermal Necrolysis-Like Lupus Erythematous Presentation Following SARS-CoV-2 Infection

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • J Med Cases . Toxic Epidermal Necrolysis-Like Lupus Erythematous Presentation Following SARS-CoV-2 Infection


    J Med Cases


    . 2022 Feb;13(2):89-93.
    doi: 10.14740/jmc3880. Epub 2022 Feb 16.
    Toxic Epidermal Necrolysis-Like Lupus Erythematous Presentation Following SARS-CoV-2 Infection


    Ana Luisa Nunes 1 , Leonor Simoes 2 , Carolina Figueiredo 3 , Ruben Carvalho 4 , Jandira Lima 1 , Rui M Santos 1



    Affiliations

    Abstract

    Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects multiple organs. Infectious agents have been implicated in the pathogenesis of SLE. The emergent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a pro-inflammatory cytokine storm and has been linked to autoimmune phenomena, which can lead to the onset of autoimmune diseases. We report the case of a 70-year-old patient who developed a toxic epidermal necrolysis (TEN)-like subacute cutaneous lupus (SCL) as a severe presentation of SLE, 1 month after SARS-CoV-2 infection. After excluding other causes of SLE, treatment was initiated with a successful outcome.

    Keywords: COVID-19; SARS-CoV-2; Subacute cutaneous lupus; Systemic lupus erythematous; Toxic epidermal necrolysis.

Working...
X